NASDAQ:BBP

Bioshares Biotechnology Products Fund ETF Forecast

etoro logo Buy BBP
*Your capital is at risk
$93.89
-2.51 (-2.60%)
At Close: Jul 31, 2026
AI Analysis AI Analysis of BBP AI-Powered Market Insights
ETF Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BBP to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Evaluation of BioShares Biotechnology Products Fund ETF downgraded after the last trading session
(Updated on Jul 31, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 31, 2026

The BioShares Biotechnology Products Fund ETF price fell by -2.60% on the last day (Friday, 31st Jul 2026) from $96.40 to $93.89. It has now fallen 4 days in a row. During the last trading day the ETF fluctuated 4.52% from a day low at $93.36 to a day high of $97.58. The price has fallen in 7 of the last 10 days and is down by -3.64% for this period. Volume has increased on the last day by 6 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 13 thousand shares were bought and sold for approximately $1.20 million.

The ETF lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $93.52 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the ETF is expected to rise 16.89% during the next 3 months and, with a 90% probability hold a price between $109.32 and $126.16 at the end of this 3-month period.

BBP Signals & Forecast

There are few to no technical positive signals at the moment. The BioShares Biotechnology Products Fund ETF holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the ETF. On corrections up, there will be some resistance from the lines at $96.61 and $95.70. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, July 08, 2026, and so far it has fallen -9.36%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). BioShares Biotechnology Products Fund gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for BioShares Biotechnology Products Fund ETF

BioShares Biotechnology Products Fund finds support from accumulated volume at $90.39 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This ETF is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the ETF moved $4.22 (4.52%) between high and low. For the last week, the ETF has had daily average volatility of 1.48%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BBP) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect BioShares Biotechnology Products Fund to open at $94.94, and during the day (based on 14 day Average True Range), to move between $93.01 and $94.77, which gives a possible trading interval of +/-$1.76 (+/-1.89%) up or down from last closing price. If BioShares Biotechnology Products Fund takes out the full calculated possible swing range there will be an estimated 1.89% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $97.06 (3.38%) than the support at $90.39 (3.73%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is BioShares Biotechnology Products Fund ETF A Buy?

The BioShares Biotechnology Products Fund ETF holds several negative signals and despite the positive trend, we believe BioShares Biotechnology Products Fund will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this ETF. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this ETF since the last evaluation from a Buy to a Sell candidate.

Current score: -4.611 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $94.94 ( 1.12%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BBP Performance

Trading levels for BBP

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 99.16 5.62%
R2 97.55 3.90%
R1 96.56 2.84%
Price 93.89
S1 93.33 -0.595%
S2 92.34 -1.66%
S3 90.72 -3.37%

Accumulated Volume Support & Resistance Levels

Level Price
R3 103.44 10.17%
R2 97.90 4.27%
R1 97.06 3.38%
Price 93.89
S1 90.39 -3.73%
S2 88.04 -6.23%
S3 86.20 -8.19%

BBP Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Dec 19, 2017 Dec 20, 2017 Dec 27, 2017 $0.0720 0.176%
2 Dec 21, 2015 Dec 21, 2015 Dec 29, 2015 $0.397 1.27%

FAQ

What is the symbol for BioShares Biotechnology Products Fund ETF and on which exchange is it traded?
The symbol for BioShares Biotechnology Products Fund is BBP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BioShares Biotechnology Products Fund ETF?
The BioShares Biotechnology Products Fund ETF holds several negative signals and despite the positive trend, we believe BioShares Biotechnology Products Fund will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this ETF. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this ETF since the last evaluation from a Buy to a Sell candidate.

How to buy BioShares Biotechnology Products Fund ETF?
BioShares Biotechnology Products Fund ETF can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioShares Biotechnology Products Fund ETF.

What's the current price of BioShares Biotechnology Products Fund ETF?
As of the end of day on the Jul 31, 2026, the price of an BioShares Biotechnology Products Fund (BBP) share was $93.89.

What is the 52-week high and low for BioShares Biotechnology Products Fund ETF?
The 52-week high for BioShares Biotechnology Products Fund ETF is $105.21 and the 52-week low is $60.91.

What is the market capitalization of BioShares Biotechnology Products Fund ETF?
As of the Jul 31, 2026, the market capitalization of BioShares Biotechnology Products Fund is 38.248M.
Click to get the best stock tips daily for free!
ABOUT BIOSHARES BIOTECHNOLOGY PRODUCTS FUND
The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the BioShares Biotechnology Products Index. Under normal market conditions, the fund will invest not less than 80% of its total assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering or product can...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE